Search results
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Sumitomo Mitsui Trust Holdings...
ETF DAILY NEWS· 2 days agoSumitomo Mitsui Trust Holdings Inc. lowered its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report ...
Zurcher Kantonalbank Zurich Cantonalbank Buys 12,003 Shares of Teva Pharmaceutical Industries...
ETF DAILY NEWS· 2 days agoZurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report ...
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For...
Benzinga· 1 day agoVanda had filed a lawsuit in 2018 against Teva and Apotex in Delaware, alleging patent infringement...
11 Best Low Price Pharma Stocks To Invest In
Insider Monkey via Yahoo Finance· 2 days agoIn this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want...
Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
Zacks· 5 days agoApril 19, 2024 – Today, Zacks Equity Research discusses Teva Pharmaceuticals (TEVA Quick QuoteTEVA - Free Report) , Dr. Reddy’s Laboratories ...
FDA approves Alvotech biosimilar of J&J top-selling drug Stelara (NYSE:TEVA)
Seeking Alpha· 7 days agoThe FDA has approved Alvotech’s biosimilar of Johnson & Johnson’s (JNJ) Stelara, with Teva hoping to...
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...
Morningstar· 4 days agoAlvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today a long-term agreement with a ...
Peninsula VC adds more than $100 million, brings on former Pfizer exec as partner - San Francisco...
The Business Journals· 6 days agoA leading biotech venture capital firm said it's added more than $100 million in capital and a seasoned industry voice in former Pfizer Inc. executive Uwe Schoenbeck. The ...